» Articles » PMID: 31138863

Internalization, Distribution, and Activity of Peptide H2 Against the Intracellular Multidrug-resistant Bovine Mastitis-causing Bacterium Staphylococcus Aureus

Overview
Journal Sci Rep
Specialty Science
Date 2019 May 30
PMID 31138863
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Bovine mastitis is mainly caused by Staphylococcus aureus, which is difficult to eliminate, prone to escape from antibacterial agents, and may cause recurring infections due to the intracellular nature of its infection and multidrug resistance. In this study, the intracellular activities of the NZ2114 derivative peptide H18R (H2) against methicillin-resistant S. aureus (MRSA) and multidrug-resistant bovine S. aureus strains were investigated in bovine mammary epithelial MAC-T cells and mouse mammary glands. The minimum inhibitory concentrations of H2 against S. aureus were 0.5‒1 μg/ml; H2 displayed a lower cytotoxicity than its parental peptide NZ2114 (survival rates of MAC-T cells: 100% [H2 treatment] vs 60.7% [NZ2114 (256 μg/ml) treatment]). H2 was internalized into MAC-T cells mainly via clathrin-mediated endocytosis, and distributed in the cytoplasm. The intracellular inhibition rates against MRSA ATCC43300, the mastitis isolates S. aureus CVCC 3051 and E48 were above 99%, 99%, and 94%, respectively; these were higher than those in case of vancomycin (23-47%). In the mouse model of S. aureus E48-induced mastitis, after treatment with 100 μg of H2 and vancomycin, bacterial numbers in each mammary gland were reduced by 3.96- and 1.59-log CFU, respectively. Additionally, similar to NZ2114 and vancomycin, H2 alleviated the histopathological damage of the mammary tissue and polymorphonuclear neutrophil infiltration in the alveoli. These results suggest that H2 can be used as a safe and effective candidate for treating S. aureus-induced mastitis.

Citing Articles

Bovine mastitis, a worldwide impact disease: Prevalence, antimicrobial resistance, and viable alternative approaches.

Morales-Ubaldo A, Rivero-Perez N, Valladares-Carranza B, Velazquez-Ordonez V, Delgadillo-Ruiz L, Zaragoza-Bastida A Vet Anim Sci. 2023; 21:100306.

PMID: 37547227 PMC: 10400929. DOI: 10.1016/j.vas.2023.100306.


Editorial: Community series in antimicrobial peptides: Molecular design, structure function relationship and biosynthesis optimization.

Yang N, Aminov R, Franco O, de la Fuente-Nunez C, Wang J Front Microbiol. 2023; 14:1125426.

PMID: 36726373 PMC: 9885265. DOI: 10.3389/fmicb.2023.1125426.


Cell-Penetrating Antimicrobial Peptides with Anti-Infective Activity against Intracellular Pathogens.

Cruz G, Santos A, de Brito E, Radis-Baptista G Antibiotics (Basel). 2022; 11(12).

PMID: 36551429 PMC: 9774436. DOI: 10.3390/antibiotics11121772.


The dual antimicrobial and immunomodulatory roles of host defense peptides and their applications in animal production.

Wu D, Fu L, Wen W, Dong N J Anim Sci Biotechnol. 2022; 13(1):141.

PMID: 36474280 PMC: 9724304. DOI: 10.1186/s40104-022-00796-y.


Effect of NZ2114 against biofilms and its application in murine mastitis model.

Yang N, Zhang Q, Mao R, Hao Y, Ma X, Teng D Front Microbiol. 2022; 13:1010148.

PMID: 36187987 PMC: 9521165. DOI: 10.3389/fmicb.2022.1010148.


References
1.
Wieczorek M, Jenssen H, Kindrachuk J, Scott W, Elliott M, Hilpert K . Structural studies of a peptide with immune modulating and direct antimicrobial activity. Chem Biol. 2010; 17(9):970-80. DOI: 10.1016/j.chembiol.2010.07.007. View

2.
Almeida R, Matthews K, Cifrian E, Guidry A, Oliver S . Staphylococcus aureus invasion of bovine mammary epithelial cells. J Dairy Sci. 1996; 79(6):1021-6. DOI: 10.3168/jds.S0022-0302(96)76454-8. View

3.
Bouchard D, Rault L, Berkova N, Le Loir Y, Even S . Inhibition of Staphylococcus aureus invasion into bovine mammary epithelial cells by contact with live Lactobacillus casei. Appl Environ Microbiol. 2012; 79(3):877-85. PMC: 3568545. DOI: 10.1128/AEM.03323-12. View

4.
Gomes F, Henriques M . Control of Bovine Mastitis: Old and Recent Therapeutic Approaches. Curr Microbiol. 2015; 72(4):377-82. DOI: 10.1007/s00284-015-0958-8. View

5.
Mygind P, Fischer R, Schnorr K, Hansen M, Sonksen C, Ludvigsen S . Plectasin is a peptide antibiotic with therapeutic potential from a saprophytic fungus. Nature. 2005; 437(7061):975-80. DOI: 10.1038/nature04051. View